SENS-401 (R-Azasetron Besylate)
SENS-401-203
Phase 2 small_molecule completed
Quick answer
SENS-401 (R-Azasetron Besylate) for Hearing Loss is a Phase 2 program (small_molecule) at Orion Laboratories Pty. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orion Laboratories Pty.
- Indication
- Hearing Loss
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed